The Rx medical food is specially formulated food for dietary management or supportive therapy for medical condition such as pulmonary and metabolic disorders. The medical food is different than dietary supplements and prescription drug, as it is generally nutrient based, protein-based and contains minerals, vitamins. The medical food does not require pre-market approval. The American Food and Drug Administration (FDA) regulated medical food as drugs, because they were intended to affect the function of the body.
MARKET DYNAMICS
The global Rx medical food market is expected to grow in upcoming years. Factors driving the growth of market are increasing demand of medical food in management of chronic condition, public and private initiatives in clinical nutrition and others. Moreover the increasing investment by market players in research and development of medical food is expected to offer growth market opportunities.
MARKET SCOPE
The "Global Rx Medical Food Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Rx medical food market with detailed market segmentation by product type, therapeutic application, distribution channel and geography. The global Rx medical food market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Rx medical food market is segmented on the basis of product type, therapeutic application and distribution channel. Based on product type, the market is segmented as pills, powders, liquids and others. Based on therapeutic application the Rx medical food market is segmented into pain management, sleep disorder, neurological disorder, GI disorder, pulmonary disorders, metabolic disorders and others. On the basis of distribution channel, the market is segmented into retail pharmacies and online pharmacies.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Rx medical food market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Rx medical food market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Rx medical food market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Rx medical food market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the Rx medical food market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rx medical food market are anticipated to lucrative growth opportunities in the future with the rising demand for Rx medical food in the global market. Below mentioned is the list of few companies engaged in the Rx medical food market.
The report also includes the profiles of key Rx medical food market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Abbott.
-Danone
-Mead Johnson & Company, LLC.
-Fresenius Kabi AG
-Nestle
-Primus Pharmaceuticals, Inc.
-TARGETED MEDICAL PHARMA INC
-Alfasigma S.p.A.
-Pivotal Therapeutics
-Enzymotec Ltd.
(image)